Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.91 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL31533366 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL31314243 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL30991839 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL2771868 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL9133500 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL31316366 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Tartaric Acid SCHEMBL31289378 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL7776179 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL905466 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Tartaric Acid SCHEMBL29494971 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118320576-A | Carbon dioxide trapping system and heat pump type waste heat regeneration and utilization module thereof | 北京大学 | 2024-07-12 | — | — | CN | claimed |
| CN-118328587-A | Self-heating recycle's carbon dioxide entrapment system | 北京大学 | 2024-07-12 | — | — | CN | claimed |
| US-20200291040-A1 | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF | ABBVIE INC (US) | 2020-09-17 | — | — | US | claimed |
| US-20190023714-A1 | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF | AbbVie Deutschland GmbH & Co. KG (DE) | 2019-01-24 | — | — | US | claimed |
| CN-105025898-B | Histamine H4The yl pyrimidines conditioning agent of benzimidazole 2 of acceptor | 詹森药业有限公司 | 2018-01-23 | — | — | CN | claimed |
| CN-105025898-A | Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor | JANSSEN PHARMACEUTICA NV | 2015-11-04 | — | — | CN | claimed |
| US-6706122-B2 | DISSOLVING INTERMEDIATE CARRIER WITH HYDROGEN PEROXIDE SOLUTION THROUGH PORES | UNAXIS TRADING AG (CH) | 2004-03-16 | — | — | US | claimed |
| US-20010013356-A1 | Method for removing layers of hard material | OERLIKON TRADING AG, TRUBBACH (CH) | 2001-08-16 | — | — | US | claimed |
| WO-1994012624-A1 | CRYSTAL CARRIERS FOR CELL CULTURE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1994-06-09 | — | — | WO | claimed |
| US-4425998-A | Protective packaging for thermolabile goods using compounds with melting points slightly below thermosensitive temperature of the goods | PYMAH CORPORATION (US) | 1984-01-17 | — | — | US | claimed |
| US-20260137097-A1 | CHOCOLATE PRODUCTS, INGREDIENTS, PROCESSES AND USES | SOC DES PRODUITS NESTLE S A (CH) | 2026-05-21 | — | — | US | disclosed |
| US-12568988-B2 | Chocolate products, ingredients, processes and uses | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-10 | — | — | US | disclosed |
| US-12527333-B2 | Foodstuff products, ingredients, processes and uses | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-01-20 | — | — | US | disclosed |
| WO-2025262103-A1 | SUPERIOR PROMOTERS FOR FUNGAL PROTEIN PRODUCTION | BASF SE (DE) | 2025-12-26 | — | — | WO | disclosed |
| EP-4655405-A1 | NEW GENOMIC INTEGRATION SITE FOR FUNGAL PROTEIN AND FINE CHEMICALS PRODUCTION | BASF SE (DE) | 2025-12-03 | — | — | EP | disclosed |
| EP-0297815-B1 | Fluorine containing renin inhibitors | PFIZER (US) | 1994-07-27 | — | — | EP | disclosed |
| WO-1994012624-A1 | CRYSTAL CARRIERS FOR CELL CULTURE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1994-06-09 | — | — | WO | disclosed |
| US-5203911-A | CONTROLLED ELECTROLESS PLATING | SHIPLEY COMPANY INC. (US) | 1993-04-20 | — | — | US | disclosed |
| US-4855303-A | Fluorine containing renin inhibitors | PFIZER INC. (US) | 1989-08-08 | — | — | US | disclosed |
| EP-0297815-A2 | Fluorine containing renin inhibitors | PFIZER INC. (US) | 1989-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200291040-A1 | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF | CNKSR1, JAK2, TNF | TSHR 209/4885OR51E2 4764/4885TP53 1757/4885 |
| US-20190023714-A1 | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF | CNKSR1, JAK2, TNF | TSHR 259/4885OR51E2 4748/4885TP53 2038/4885 |
| US-20260137097-A1 | CHOCOLATE PRODUCTS, INGREDIENTS, PROCESSES AND USES | TEC, P2RY10, TAS2R10 | TSHR 4153/4885OR51E2 2920/4885TP53 3729/4885 |
| US-12568988-B2 | Chocolate products, ingredients, processes and uses | CROCC, CSPP1, CNOT9 | TSHR 4388/4885OR51E2 3899/4885TP53 4074/4885 |
| US-12527333-B2 | Foodstuff products, ingredients, processes and uses | TREH, LCT, ALPP | TSHR 4231/4885OR51E2 4702/4885TP53 3610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.